Imagining a better future for all people with type 1 diabetes mellitusShow others and affiliations
2019 (English)In: Nature Reviews Endocrinology, ISSN 1759-5029, E-ISSN 1759-5037, Vol. 15, no 11, p. 623-624Article in journal, Editorial material (Other academic) Published
Abstract [en]
For a person with type 1 diabetes mellitus, lifelong insulin treatment is the only therapeutic option. However, increased blood levels of glucose are just a symptom of impaired beta-cell function. Approaching the centenary of the first insulin injection, broadening of international therapeutic guidelines to improve diagnostics, as well as monitor and preserve beta-cell function, is warranted.
Place, publisher, year, edition, pages
NATURE PUBLISHING GROUP , 2019. Vol. 15, no 11, p. 623-624
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:liu:diva-161375DOI: 10.1038/s41574-019-0257-8ISI: 000489751400001PubMedID: 31471596OAI: oai:DiVA.org:liu-161375DiVA, id: diva2:1367521
Note
Funding Agencies|Swedish Medical Research CouncilSwedish Medical Research Council (SMRC); Sten A Olssons Foundation; Ernfors Family Fund; Barndiabetesfonden (The Swedish Child Diabetes Foundation); Swedish Diabetes Association; Novo Nordisk FoundationNovo Nordisk; Diabetes Wellness Foundation; Ake Wiberg Foundation; Tore Nilsson Foundation; Diabetes Research Institute Foundation; Helmsley Charitable Trust; JDRFJuvenile Diabetes Research Foundation
2019-11-042019-11-042020-02-20